Related Experiment Videos

Familial hypoalphalipoproteinemia in premature coronary artery disease

J Genest1, J M Bard, J C Fruchart

  • 1Lipid Metabolism Laboratory, Tufts University, Boston, Mass. 02111.

Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|December 1, 1993
PubMed

Insights

Familial hypoalphalipoproteinemia (HA) is linked to premature heart disease. Common forms involve increased apoB lipoproteins and smaller, denser LDL particles, affecting about half of offspring.

Area of Science:

  • Cardiovascular Genetics
  • Lipid Metabolism Disorders
  • Atherosclerosis Research

Background:

  • Hypoalphalipoproteinemia (HA) is frequently observed in individuals with premature coronary artery disease.
  • Understanding the common familial forms of HA is crucial for risk stratification and management.

Observation:

  • This study investigated 102 families with probands exhibiting premature coronary artery disease, identifying HA in 39.2%.
  • Familial forms included familial hypertriglyceridemia with HA (FTgHA), familial combined hyperlipidemia (FCH), and familial HA (FHA).
  • Measurements included apolipoproteins (apoA-I, B, C-III, E) and lipoprotein particles (LpA-I, LpA-I:A-II, LpB:E, LpB:C-III).

Findings:

  • Familial HA forms showed decreased apoA-I and lower LpA-I/LpA-I:A-II levels compared to healthy controls.
  • All familial HA groups exhibited significantly higher apoB levels, with the highest in FCH.
  • Smaller, denser LDL particles were noted in all familial HA forms, indicating an increased number of atherogenic LDL particles.

Implications:

  • Common familial HA forms associated with coronary artery disease represent a spectrum of disorders.
  • Elevated apoB-containing lipoproteins, particularly LpB:E particles and small, dense LDL, are key characteristics.
  • Approximately half of the offspring in affected families may inherit these lipoprotein abnormalities.

Related Concept Videos